Immediate Impact
30 standout
Citing Papers
Safety and Immunogenicity of an mRNA-Based RSV Vaccine Including a 12-Month Booster in a Phase 1 Clinical Trial in Healthy Older Adults
2024 Standout
ESKAPE pathogens: antimicrobial resistance, epidemiology, clinical impact and therapeutics
2024 Standout
Works of Thomas Chandler being referenced
23-Valent Pneumococcal Polysaccharide Vaccination Does Not Prevent Community-Acquired Pneumonia Hospitalizations Due to Vaccine-Type Streptococcus pneumoniae
2022
371. Adding sputum and saliva to nasopharyngeal swab samples for PCR detection of Respiratory Syncytial Virus in adults hospitalized with acute respiratory illness may double case detection
2022
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Thomas Chandler | 113 | 34 | 51 | 36 | 36 | 228 | |
| Melissa Ward‐Peterson | 55 | 20 | 43 | 15 | 36 | 286 | |
| Maren Dreier | 69 | 16 | 25 | 33 | 35 | 288 | |
| Luigi Matera | 116 | 7 | 57 | 79 | 25 | 242 | |
| Titilope Olanipekun | 41 | 10 | 60 | 11 | 42 | 272 | |
| Makoto Kosaka | 64 | 35 | 40 | 39 | 48 | 296 | |
| Jorge Alave | 65 | 8 | 138 | 19 | 26 | 251 | |
| Pavadee Poowuttikul | 24 | 5 | 20 | 52 | 39 | 242 | |
| Donna D. Gardner | 36 | 7 | 47 | 99 | 24 | 197 | |
| Ashley Quigley | 76 | 12 | 63 | 54 | 30 | 290 | |
| Floriana D’Ambrosio | 76 | 12 | 89 | 10 | 24 | 266 |
All Works
Login with ORCID to disown or claim papers
Loading papers...